A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.
USA115th CongressS-2885| Senate
| Updated: 5/17/2018
Tina Smith
Democratic Senator
Minnesota
Cosponsors (1)
Banking, Housing, and Urban Affairs Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Disclosing Pharmaceutical Company Windfall Profits Act of 2018 This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Finance and Financial Sector
A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.
USA115th CongressS-2885| Senate
| Updated: 5/17/2018
Disclosing Pharmaceutical Company Windfall Profits Act of 2018 This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Tina Smith
Democratic Senator
Minnesota
Cosponsors (1)
Banking, Housing, and Urban Affairs Committee
Finance and Financial Sector
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted